Join a world class panel of leading gene editing professionals at Oxford Global’s 4th Annual Genome Editing Congress.
Gene Editing is being driven by genomics and data analysis technologies. This congress focusses on the new opportunities for drug discovery presented by these conditions. We will also examine how regulatory and reimbursement challenges can be resolved to enable the implementation of personalised treatments.
Putting you in contact with over 250 senior level delegates, this is the event for professionals looking to network and collaborate with leading experts in the field.
Our esteemed speaker list features Zoltán Ivics, Head of Division, Paul Ehrlich Institute, presenting on non-viral genome editing transposon vectors, and Adriana Beltran, Director Human Pluripotent Stem Cell Core, University of North Carolina Chapel Hill who will provide insights on CRISPR stem cell models of genetic disease.